Evidence map›Paper›PMID 38109351›Full record

ArticleCirculation2024

Reduced Ejection Fraction in Elite Endurance Athletes: Clinical and Genetic Overlap With Dilated Cardiomyopathy.

Guido Claessen, Ruben De Bosscher, Kristel Janssens, Paul Young, Christophe Dausin, Mathias Claeys, Piet Claus, Kaatje Goetschalckx, Jan Bogaert, Amy M Mitchell and 20 more

Open access · hybridAbstract read
In one paragraph

Article in Circulation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
15.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 39 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Observational
  17. Review
  18. Article
  19. Cardiac fibrosis: from mechanisms and models to medicines.Trends in pharmacological sciences · 2025
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 11 institutions in 2 countries.

Guido Claessen *Faculty of Medicine and Life Sciences, Limburg Clinical Research Center (LCRC), Hasselt University, Biomedical Research Institute, Diepenbeek, Belgium (G.C., O.G., L.H.).ORCID 0000-0001-8261-6666
Ruben De Bosscher *Jessa Ziekenhuis, Belgium. Department of Cardiovascular Sciences (G.C., R.D.B., M.C., P.C., T.R., R.W., A.L.G.), KU Leuven, Belgium.
Kristel JanssensHEART (Heart Exercise and Research Trials) Lab, St Vincent's Institute of Medical Research, Fitzroy, Australia (K.J., A.M.M., A.L.G.).
Paul YoungVictor Chang Cardiac Research Institute, Darlinghurst, Australia (P.Y., M.O., M.S., E.R., E.G., R.J., D.F., A.L.G.).ORCID 0000-0002-5789-563X
Christophe DausinDepartment of Movement Sciences (C.D.), KU Leuven, Belgium.
Mathias ClaeysJessa Ziekenhuis, Belgium. Department of Cardiovascular Sciences (G.C., R.D.B., M.C., P.C., T.R., R.W., A.L.G.), KU Leuven, Belgium.ORCID 0000-0002-3998-5340
Piet ClausJessa Ziekenhuis, Belgium. Department of Cardiovascular Sciences (G.C., R.D.B., M.C., P.C., T.R., R.W., A.L.G.), KU Leuven, Belgium.ORCID 0000-0002-2013-639X
Kaatje GoetschalckxDepartment of Cardiovascular Diseases (R.D.B., K.G., T.R., R.W.), University Hospitals Leuven, Belgium.ORCID 0000-0002-5419-7684
Jan BogaertDepartment of Imaging and Pathology (J.B.), KU Leuven, Belgium.ORCID 0000-0001-7495-9183
Amy M MitchellHEART (Heart Exercise and Research Trials) Lab, St Vincent's Institute of Medical Research, Fitzroy, Australia (K.J., A.M.M., A.L.G.).
Michael D FlanneryDepartment of Medicine, University of Melbourne, Parkville, Australia (M.D.F., J.M.K., A.L.G.).
Adrian D ElliottCentre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Australia (A.D.E., P.S.).
Chenglong YuDepartment of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (C.Y., P.L.).ORCID 0000-0002-0546-2779
Olivier GhekiereFaculty of Medicine and Life Sciences, Limburg Clinical Research Center (LCRC), Hasselt University, Biomedical Research Institute, Diepenbeek, Belgium (G.C., O.G., L.H.).
Tomas RobynsJessa Ziekenhuis, Belgium. Department of Cardiovascular Sciences (G.C., R.D.B., M.C., P.C., T.R., R.W., A.L.G.), KU Leuven, Belgium.ORCID 0000-0002-8676-4874
Caroline M Van De HeyningDepartment of Cardiovascular Sciences, University of Antwerp, Belgium (C.M.V.D.H., H.H.).
Prashanthan SandersCentre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Australia (A.D.E., P.S.).ORCID 0000-0003-3803-8429
Jonathan M KalmanDepartment of Medicine, University of Melbourne, Parkville, Australia (M.D.F., J.M.K., A.L.G.).ORCID 0000-0002-6618-7184
Monique OhanianVictor Chang Cardiac Research Institute, Darlinghurst, Australia (P.Y., M.O., M.S., E.R., E.G., R.J., D.F., A.L.G.).
Magdalena SokaVictor Chang Cardiac Research Institute, Darlinghurst, Australia (P.Y., M.O., M.S., E.R., E.G., R.J., D.F., A.L.G.).
Emma RathVictor Chang Cardiac Research Institute, Darlinghurst, Australia (P.Y., M.O., M.S., E.R., E.G., R.J., D.F., A.L.G.).ORCID 0000-0002-8430-5236
Eleni GiannoulatouVictor Chang Cardiac Research Institute, Darlinghurst, Australia (P.Y., M.O., M.S., E.R., E.G., R.J., D.F., A.L.G.).ORCID 0000-0002-7084-6736
Renee JohnsonVictor Chang Cardiac Research Institute, Darlinghurst, Australia (P.Y., M.O., M.S., E.R., E.G., R.J., D.F., A.L.G.).ORCID 0000-0002-8979-2096
Paul LacazeDepartment of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (C.Y., P.L.).ORCID 0000-0002-0902-6798
Lieven HerbotsFaculty of Medicine and Life Sciences, Limburg Clinical Research Center (LCRC), Hasselt University, Biomedical Research Institute, Diepenbeek, Belgium (G.C., O.G., L.H.).
Rik WillemsJessa Ziekenhuis, Belgium. Department of Cardiovascular Sciences (G.C., R.D.B., M.C., P.C., T.R., R.W., A.L.G.), KU Leuven, Belgium.ORCID 0000-0002-5469-9609
Diane Fatkin *Victor Chang Cardiac Research Institute, Darlinghurst, Australia (P.Y., M.O., M.S., E.R., E.G., R.J., D.F., A.L.G.).ORCID 0000-0002-9010-9856
Hein Heidbuchel *Department of Cardiovascular Sciences, University of Antwerp, Belgium (C.M.V.D.H., H.H.).ORCID 0000-0001-9301-8127
André La Gerche *Jessa Ziekenhuis, Belgium. Department of Cardiovascular Sciences (G.C., R.D.B., M.C., P.C., T.R., R.W., A.L.G.), KU Leuven, Belgium.
Pro@Heart Consortium
Victor Chang Cardiac Research Institute · AUJessa Hospital · BEKU Leuven · BEMonash University · AURoyal Adelaide Hospital · AUSt Vincents Institute of Medical Research · AUThe University of Melbourne · AUUniversity of Antwerp · BEGeographic Information Management (Belgium) · BEHartcentrum Hasselt · BEThe Royal Melbourne Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExercise-induced cardiac remodeling can be profound, resulting in clinical overlap with dilated cardiomyopathy, yet the significance of reduced ejection fraction (EF) in athletes is unclear. The aim is to assess the prevalence, clinical consequences, and genetic predisposition of reduced EF in athletes.

methodsYoung endurance athletes were recruited from elite training programs and underwent comprehensive cardiac phenotyping and genetic testing. Those with reduced EF using cardiac magnetic resonance imaging (defined as left ventricular EF <50%, or right ventricular EF <45%, or both) were compared with athletes with normal EF. A validated polygenic risk score for indexed left ventricular end-systolic volume (LVESVi-PRS), previously associated with dilated cardiomyopathy, was assessed. Clinical events were recorded over a mean of 4.4 years.

resultsOf the 281 elite endurance athletes (22±8 years, 79.7% male) undergoing comprehensive assessment, 44 of 281 (15.7%) had reduced left ventricular EF (N=12; 4.3%), right ventricular EF (N=14; 5.0%), or both (N=18; 6.4%). Reduced EF was associated with a higher burden of ventricular premature beats (13.6% versus 3.8% with >100 ventricular premature beats/24 h;

conclusionsReduced EF occurs in approximately 1 in 6 elite endurance athletes and is related to genetic predisposition in addition to exercise training. Genetic and imaging markers may help identify endurance athletes in whom scrutiny about long-term clinical outcomes may be appropriate. REGISTRATION: URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374976&isReview=true; Unique identifier: ACTRN12618000716268.

Indexed as

AthletesCardiomyopathy, DilatedStroke VolumeAdolescentAdultFemaleGenetic Predisposition to DiseaseHumansMalePhysical EnduranceVentricular Function, LeftVentricular RemodelingYoung Adultarrhythmias, cardiaccardiomegalycardiomegaly, exercise-inducedcardiomyopathiesfibrosisgeneticsgenome

Identifiers

PMID38109351
PMCPMC11062611
OpenAlexW4389958242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.